Relationships Between Exercise and Appetite in Women With Loss of Control Eating
Launched by OHIO UNIVERSITY · Sep 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how exercise affects appetite in women who struggle with loss of control eating, which can include conditions like binge-eating disorder and bulimia nervosa. The study is currently looking for participants aged between 18 and 45 who have experienced episodes of loss of control eating at least 12 times in the last three months. To qualify, women must also be taking hormonal contraception and have a certain level of fitness. Additionally, it’s important that participants enjoy chocolate since the study will involve eating specific foods provided by the researchers.
If you decide to take part in this study, you’ll be asked to engage in exercise and follow a diet with foods chosen by the study team. The goal is to better understand the connection between physical activity and appetite in women dealing with these eating disorders. Before joining, it's important to note that there are certain health conditions and factors that could exclude someone from participating, such as being underweight, having recent pregnancy or breastfeeding experience, or having specific medical conditions affecting appetite. This is an exciting opportunity to help researchers learn more about this important topic!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Engage in loss of control eating at least 12 times in the last three months
- • Clinically significant eating disorder-related impairment (CIA \> 15)
- • Taking hormonal contraception
- • Minimum VO2max of 50th percentile for age and sex assigned at birth
- • Be willing to eat study-provided foods
- • Likes chocolate (at least 6/10 on 10 point scale)
- Exclusion Criteria:
- • BMI \< 18.5 kgm/2
- • Medical conditions that affect appetite or weight (e.g., diabetes mellitus, thyroid disease)
- • Recent pregnancy or breastfeeding (prior 6 months)
- • Relevant food allergies (e.g., wheat, chocolate)
- • Specific phobia, blood-injection-injury type
- • Medical condition that precludes safe participation in exercise (e.g., stress fracture)
- • Medications that acutely affect appetite (e.g., GLP-1 agonists; psychiatric medications allowed)
About Ohio University
Ohio University is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong commitment to improving patient outcomes, the university leverages its extensive resources and interdisciplinary expertise to conduct rigorous research across various medical fields. Ohio University collaborates with healthcare professionals, researchers, and community partners to ensure that clinical trials are designed with the highest ethical standards and scientific integrity. Through these efforts, the institution aims to contribute valuable insights to the medical community and enhance the quality of care for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported